Ex-Medicare chief Slavitt adds partners to venture firm, which will invest in the ‘most vulnerable Americans’

May 10, 2018

Former Medicare chief Andy Slavitt has added two partners to his new venture capital firm, which aims to find profits in serving the poorest, sickest, and most vulnerable Americans.

Slavitt’s Town Hall Ventures is officially launched at HLTH in Las Vegas. Joining Slavitt are Trevor Price and David Whelan from Oxeon Partners, a New York-based company with an executive search and investment arm.

Town Hall got its name from a series of visits Slavitt made to town halls across the country to answer questions about the Affordable Care Act, as President Donald Trump and congressional Republicans aimed to repeal and replace it last year. Slavitt, who ran Medicare under President Barack Obama and helped implement the ACA, was a vocal advocate of upholding the legislation, known as Obamacare.

Slavitt has no interest in jumping into the fray of Silicon Valley health-tech investors, who have sought outsized returns in wellness apps, tools for urban professionals, and technologies that provide an alternative to seeing a doctor in person.

Rather, Slavitt said he’s looking for investments in companies that are trying to improve lives for the most at-risk populations. That includes entrepreneurs seeking solutions to end the opioid epidemic and those targeting mental health, loneliness, maternity, kidney dialysis, and care to people in the earliest and latest stages of life.

Veteran venture capitalist John Doerr, who made high-profile bets on Amazon and Google, is advising the team. Slavitt said Doerr told the partners he wanted to get involved because the firm is going after the most underinvested part of healthcare. Longtime health investor Ann Lamont is also serving as an advisor.

Town Hall has already invested in four companies:

  • Cityblock, which was built in partnership with Alphabet to provide services to poor, urban populations.
  • WelbeHealth, a start-up serving the frail elderly.
  • Aetion, which is gathering real-world evidence around drug pricing.
  • Somatus, which is developing technologies for people with chronic kidney disease.

The firm plans to write checks that range from $1 million to $5 million but doesn’t intend to lead financing rounds. Slavitt declined to comment on the size of the fund or provide names of its limited partners.

Price and Whelan bring with them a track record of investing in so-called tech-enabled services, including companies that are building new models of delivering care.

Examples include Landmark Health, which provides medical care in the home to the very sick, and VillageMD, a primary care physician group.

Slavitt said he’ll avoid software-based products that are designed to make health less personal. But he does think that technology can create better experiences and “close some of the gaps” when it comes to accessing care, such as in rural areas where the nearest doctor is miles away. Cityblock, which is composed of former Google employees, doctors and policy experts, was the firm’s first investment.

CNBC has the full article

Sponsored Recommendations

Data: The Bedrock of Digital Engagement

Join us on March 21st to discover how data serves as the cornerstone of digital engagement in healthcare. Learn from Frederick Health's transformative journey and gain practical...

Northeast Georgia Health System: Scaling Digital Transformation in a Competitive Market

Find out how Northeast Georgia Health System (NGHS) enabled digital access to achieve new patient acquisition goals in Georgia's highly competitive healthcare market.

2023 Care Access Benchmark Report for Healthcare Organizations

To manage growing consumer expectations and shrinking staff resources, forward-thinking healthcare organizations have adopted digital strategies, but recent research shows that...

Increase ROI Through AI: Unlocking Scarce Capacity & Staffing

Unlock the potential of AI to optimize capacity and staffing in healthcare. Watch now to discover how innovative AI-driven solutions can revolutionize operations, increase ROI...